AMT Medical Inc.

AMT Medical Inc. is a medical device company founded in 2011. The company is headquartered in Daxing District of Beijing, China.

AMT Medical Inc. develops and manufactures fully bioresorbable coronary stents (AMSorb) and peripheral stents (PeriSorb) by using its proprietary 3D Multi-axial Printing (3D-MAP) technology, which has advantages over the traditional laser cutting technology in producing bioresorbable vascular stents (BRS) in terms of high production efficiency and low cost. AMT's core 3D-MAP platform is a proprietary innovative additive manufacturing technology specialized for bioresorbable tubular vascular scaffolds. With AMSorb and PeriSorb already in the clinical random controlled trials (RCT) in China, AMT Medical Inc. is set to revolutionize the manufacturing of bioresorbable stents in the medical device industry for the treatment of cardiovascular diseases.

Another product, Jetfall, is a medical carbon dioxide angiographic injector that received a European MDR certificate in January 2025 and designed for injecting CO2 into the vasculature for angiographic imaging purposes.  The device is used for patients who require angiography in the venous system and arteries below the diaphragm and to guide various vascular interventional procedures. The device is for patients with renal insufficiency, iodine allergy, hyperthyroidism, risk groups with diabetes, advanced
age and other risk factors, as well as other normal applicable groups.

We sincerely welcome all companies to attend and cooperate with us. Thank you very much!